Skip to main content
. Author manuscript; available in PMC: 2022 Jun 21.
Published in final edited form as: J Public Health Manag Pract. 2018 Jul-Aug;24(4):E25–E33. doi: 10.1097/PHH.0000000000000628

TABLE.

Isoniazid-Only Latent Tuberculosis Infection Treatment Initiation and Completion Estimates, Based on Individuals in the Optum National Research Database Medical and Pharmacy Claims Data Sample With an Initial Isoniazid Prescription Filled Between July 2011 and March 2014

Measure Description Measure Value
Person/years during which treatment initiation was assessed 9 555 856.6

Number initiating treatment 1197

Annual treatment initiation rate per 100 000 insured persons 12.53

Number initiating treatment for which completion could be assessed 1074

Number completing ≥6 mo of isoniazid treatment 497

Percent completing ≥6 mo of isoniazid treatment 46.3% (95% CI, 43.3-49.3)

Of those completing ≥6 mo of isoniazid treatment
 Number completing ≥6 mo but ≤9 mo 254
 Percent completing ≥6 mo but ≤9 mo 51.1% (95% CI, 46.7-55.5)
 Number completing ≥9 mo 243
 Percent completing at ≥9 mo 48.9% (95% CI, 44.5-53.3)

Abbreviation: CI, confidence interval.